De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks
Gisbert Schneider(ETH Zurich), Petra Schneider(Roche (Switzerland)), Man‐Ling Lee(Roche (Switzerland)), Martin Ståhl(Roche (Switzerland))
Cited by 257
Related Papers
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
|Cell|2020|2.3k
Designing antimicrobial peptides: form follows function
|Nature Reviews Drug Discovery|2011|2k
A Medicinal Chemist’s Guide to Molecular Interactions
|Journal of Medicinal Chemistry|2010|1.7k
Fluorine in Medicinal Chemistry
|ChemBioChem|2004|1.5k
Intramolecular Hydrogen Bonding in Medicinal Chemistry
|Journal of Medicinal Chemistry|2010|566